These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23863705)

  • 1. Updated recommendations for use of VariZIG--United States, 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jul; 62(28):574-6. PubMed ID: 23863705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(12):212. PubMed ID: 22456121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program.
    Levin MJ; Duchon JM; Swamy GK; Gershon AA
    PLoS One; 2019; 14(7):e0217749. PubMed ID: 31269033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(8):209-10. PubMed ID: 16511443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of VariZIG in pregnancy.
    Bapat P; Koren G
    Expert Rev Vaccines; 2013 Nov; 12(11):1243-8. PubMed ID: 24093779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program.
    Gans H; Chemaly RF
    BMC Infect Dis; 2021 Jan; 21(1):46. PubMed ID: 33430796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.
    Duchon JM; Levin MJ; Gershon AA
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):449-453. PubMed ID: 31774916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
    MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.
    Manning SE; Rupprecht CE; Fishbein D; Hanlon CA; Lumlertdacha B; Guerra M; Meltzer MI; Dhankhar P; Vaidya SA; Jenkins SR; Sun B; Hull HF;
    MMWR Recomm Rep; 2008 May; 57(RR-3):1-28. PubMed ID: 18496505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-zoster virus post-exposure management and prophylaxis: A review.
    Lachiewicz AM; Srinivas ML
    Prev Med Rep; 2019 Dec; 16():101016. PubMed ID: 31890472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella-zoster immune globulin for the prevention of chickenpox. Recommendations of the Immunization Practices Advisory Committee, Centers for Disease Control.
    Ann Intern Med; 1984 Jun; 100(6):859-65. PubMed ID: 6326634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VariZIG for prophylaxis after exposure to varicella.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):69-70. PubMed ID: 16977283
    [No Abstract]   [Full Text] [Related]  

  • 16. Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin.
    Cohen A; Moschopoulos P; Stiehm RE; Koren G
    CMAJ; 2011 Feb; 183(2):204-8. PubMed ID: 21262937
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventing varicella in children with malignancies: what is the evidence?
    Fisher JP; Bate J; Hambleton S
    Curr Opin Infect Dis; 2011 Jun; 24(3):203-11. PubMed ID: 21455062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Harpaz R; Ortega-Sanchez IR; Seward JF;
    MMWR Recomm Rep; 2008 Jun; 57(RR-5):1-30; quiz CE2-4. PubMed ID: 18528318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1996 Jul; 45(RR-11):1-36. PubMed ID: 8668119
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.